AQS
$0.005
-
0.00%
Aequus Pharmaceuticals Inc.News & Events
Last updated: May 7, 2025, 6:22 PM ET
Canadian Investment Regulatory Organization Trading Halt - AQS
Canada Newswire APR 25, 2025 1:11 PM EDTCanadian Investment Regulatory Organization Trading Halt - AQS Canada NewsWire ...READ ARTICLECanadian Investment Regulatory Organization Trading Halt - AQS
PR Newswire APR 25, 2025 1:11 PM EDTCanadian Investment Regulatory Organization Trading Halt - AQS Canada NewsWire ...READ ARTICLEAequus Provides General Update and Director Changes
TheNewsWire APR 24, 2025 11:40 PM EDT(TheNewswire) VANCOUVER, BC – TheNewswire - April 24, 2025 – Aequus P...READ ARTICLEAequus Provides Update and Reports Third Quarter 2024 Financial Highlights.
TheNewsWire NOV 12, 2024 5:25 PM EST(TheNewswire) VANCOUVER, November 12 , 2024 – TheNewswire – Aequus Phar...READ ARTICLEAequus Provides Update and Reports Third Quarter 2024 Financial Highlights
TheNewsWire NOV 8, 2024 9:10 PM EST(TheNewswire) VANCOUVER – TheNewswire - November 8, 2024 – Aequus Pha...READ ARTICLEAequus Reports Second Quarter 2024 Financial Highlights and General Update
TheNewsWire AUG 29, 2024 5:45 PM EDT(TheNewswire) VANCOUVER, August 29, 2024 – TheNewswire - Aequus Pharmaceutic...READ ARTICLEAequus Provides Launch Update Zimed PF
TheNewsWire JUL 3, 2024 8:00 AM EDT(TheNewswire) VANCOUVER, BC. July 3 rd – TheNewswire – Ae...READ ARTICLEAequus Signs Exclusive Distribution Agreement with Advanced Ophthalmic Innovations for the PAUL Glaucoma Drainage Device in Canada
TheNewsWire MAY 22, 2024 8:00 AM EDT(TheNewswire) VANCOUVER – TheNewswire - May 22, 2024 – Aequus Pharmac...READ ARTICLEAequus Provides General Update and First Quarter 2024 Financial Highlights, Grant Stock Options and Financing
TheNewsWire MAY 9, 2024 7:05 PM EDT(TheNewswire) VANCOUVER, May 09, 2024 – TheNewswire – Aequus Pharmace...READ ARTICLEAequus Poised to Fill Bimatoprost 0.03% Drug Shortage in Canada
TheNewsWire MAY 7, 2024 4:10 PM EDT(TheNewswire) VANCOUVER, BC. May 7, 2024 – TheNewswire – ...READ ARTICLE